SB 452533 structure
|
Common Name | SB 452533 | ||
---|---|---|---|---|
CAS Number | 459429-39-1 | Molecular Weight | 376.29 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C18H22BrN3O | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A | |
Symbol |
GHS07, GHS09 |
Signal Word | Warning |
Use of SB 452533SB 452533 is a potent and selective TRPV1 antagonist with the pKb of 7.8[1]. |
Name | 1-(2-Bromophenyl)-3-{2-[ethyl(3-methylphenyl)amino]ethyl}ure |
---|
Description | SB 452533 is a potent and selective TRPV1 antagonist with the pKb of 7.8[1]. |
---|---|
Related Catalog | |
In Vitro | SB 452533 is potent as an antagonist at the cloned recombinant rat TRPV1 receptor in HEK293 cells with a pKb of 7.7 and a pIC50 of 7.0[1]. SB-452533 reduces phosphorylation of CAMKK2 and AMPK[2]. Western Blot Analysis[2] Cell Line: Skeletal muscle (C2C12) cells Concentration: 0, 50, 100, 200, and 400 μM Incubation Time: 30 minutes; followed by 200 μM Capsaicin treatment for another 30 min. Result: Significantly reduced Capsaicin-induced phosphorylation of AMPK and CAMKK2. |
In Vivo | Capsaicin (Cap; small dose 2 mg/kg) significantly reduces Bleomycin-induced pulmonary fibrosis in mice. SB-452533 abolishes the effects of small dose Cap[3]. Animal Model: BALB/c mice bearing pulmonary fibrosis model[3] Dosage: 2.5 mg/kg Administration: Treatment received daily drug via subcutaneous injection for 21 days Result: The effect (reduced Bleomycin-induced pulmonary fibrosis) of Cap were abolished in the presence of SB-452533. |
References |
Molecular Formula | C18H22BrN3O |
---|---|
Molecular Weight | 376.29 |
Exact Mass | 375.09500 |
PSA | 47.86000 |
LogP | 4.68290 |
Storage condition | -20°C |
Symbol |
GHS07, GHS09 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H410 |
Precautionary Statements | P273-P501 |
RIDADR | UN 3077 9 / PGIII |
~% SB 452533 CAS#:459429-39-1 |
Literature: Rami, Harshad K.; Thompson, Mervyn; Wyman, Paul; Jerman, Jeffrey C.; Egerton, Julie; Brough, Stephen; Stevens, Alexander J.; Randall, Andrew D.; Smart, Darren; Gunthorpe, Martin J.; Davis, John B. Bioorganic and Medicinal Chemistry Letters, 2004 , vol. 14, # 14 p. 3631 - 3634 |
~% SB 452533 CAS#:459429-39-1 |
Literature: Rami, Harshad K.; Thompson, Mervyn; Wyman, Paul; Jerman, Jeffrey C.; Egerton, Julie; Brough, Stephen; Stevens, Alexander J.; Randall, Andrew D.; Smart, Darren; Gunthorpe, Martin J.; Davis, John B. Bioorganic and Medicinal Chemistry Letters, 2004 , vol. 14, # 14 p. 3631 - 3634 |
Precursor 3 | |
---|---|
DownStream 0 |